Clinical characteristics and risk factors of Aeromonas bloodstream infections in patients with hematological diseases
- PMID: 35351036
- PMCID: PMC8962005
- DOI: 10.1186/s12879-022-07277-7
Clinical characteristics and risk factors of Aeromonas bloodstream infections in patients with hematological diseases
Abstract
Background: To analyze the clinical features, risk factors and outcomes of Aeromonas bloodstream infections (BSIs) in patients with hematological diseases to establish an effective optimal therapy against it.
Methods: A retrospective study was performed by reviewing medical records of patients admitted to a tertiary blood disease hospital in China. Patients with hematological diseases who suffered from Aeromonas bacteremia during January 2002 to December 2020 were enrolled in this study.
Results: A total of 63 patients who developed Aeromonas bacteremia were enrolled in the study, and 91.9% of patients were neutropenic at the onset of BSIs. The major complications were skin and soft tissue infection (SSTI) (22.2%), followed by gastroenteritis (19.0%) and pneumonia (14.3%). High carbapenem resistance rates (70.8% for imipenem, 71.4% for meropenem) were note among the cases. Furthermore, Aeromonas strains isolated from five individuals developed resistance to quinolone, β-lactams and tigecycline during the therapy. The 30-day mortality rate was 15.9%, while bacteremia with SSTI showed a much worse prognosis, with 50.0% (7/14) of the patients dying within 30 days of initiating the therapy. In the multivariate analysis, SSTI (OR = 28.72; 95% CI, 1.50-551.30; P = 0.026) and shock (OR = 47.58; 95% CI,1.06-2126.80; P = 0.046) were independent risk factors for mortality.
Conclusions: Aeromonas bacteremia usually occurred in patients with neutropenic status, and patients with SSTIs were more likely to show a worse prognosis. Carbapenems should be avoided in patients with Aeromonas BSIs and SSTIs given high resistance rate.
Keywords: Aeromonas; Bacteremia; Hematological diseases; Risk factors.
© 2022. The Author(s).
Conflict of interest statement
No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.
Figures



Similar articles
-
[Clinical features and laboratory data analysis of Aeromonas bacteremia with hematological diseases].Zhonghua Xue Ye Xue Za Zhi. 2019 Dec 14;40(12):1035-1039. doi: 10.3760/cma.j.issn.0253-2727.2019.12.013. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 32023737 Free PMC article. Chinese.
-
Antimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E coli bacteremia in adult patients with hematological disease: A monocenter retrospective study in China.Medicine (Baltimore). 2017 May;96(21):e6959. doi: 10.1097/MD.0000000000006959. Medicine (Baltimore). 2017. PMID: 28538389 Free PMC article.
-
Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae bacteremia in onco-hematological patients.J Infect Dev Ctries. 2019 May 31;13(5):357-364. doi: 10.3855/jidc.11189. J Infect Dev Ctries. 2019. PMID: 32053504
-
[Extraintestinal infection due to Aeromonas spp.: review of 38 cases].Enferm Infecc Microbiol Clin. 2007 Apr;25(4):235-41. doi: 10.1157/13100463. Enferm Infecc Microbiol Clin. 2007. PMID: 17386217 Review. Spanish.
-
Acinetobacter baumannii skin and soft-tissue infection associated with war trauma.Clin Infect Dis. 2008 Aug 15;47(4):444-9. doi: 10.1086/590568. Clin Infect Dis. 2008. PMID: 18611157 Review.
Cited by
-
Acinetobacter spp. bloodstream infection in hematological patients: a 10-year single-center study.BMC Infect Dis. 2023 Nov 14;23(1):796. doi: 10.1186/s12879-023-08789-6. BMC Infect Dis. 2023. PMID: 37964192 Free PMC article. Review.
-
Clinical Presentation, Antimicrobial Resistance, and Treatment Outcomes of Aeromonas Human Infections: A 14-Year Retrospective Study and Comparative Genomics of 2 Isolates From Fatal Cases.Clin Infect Dis. 2024 Nov 22;79(5):1144-1152. doi: 10.1093/cid/ciae272. Clin Infect Dis. 2024. PMID: 38759099 Free PMC article.
-
Good Performance of Revised Scoring Systems in Predicting Clinical Outcomes of Aeromonas Bacteremia in the Emergency Department: A Retrospective Observational Study.Diagnostics (Basel). 2024 Jan 5;14(2):124. doi: 10.3390/diagnostics14020124. Diagnostics (Basel). 2024. PMID: 38248001 Free PMC article.
-
Isolation and Identification of Aeromonas veronii in Sheep with Fatal Infection in China: A Case Report.Microorganisms. 2023 Jan 29;11(2):333. doi: 10.3390/microorganisms11020333. Microorganisms. 2023. PMID: 36838298 Free PMC article.
-
The Impact of Cefuroxime Susceptibility on Aeromonas Necrotizing Fasciitis Outcomes.Microorganisms. 2023 Nov 15;11(11):2776. doi: 10.3390/microorganisms11112776. Microorganisms. 2023. PMID: 38004787 Free PMC article.
References
-
- Kooij DVD. Properties of aeromonads and their occurrence and hygienic significance in drinking water. Zentralbl Bakteriol Mikrobiol Hyg B. 1988;187(1):1–17. - PubMed
-
- Holmes P, Niccolls LM, Sartory DP. The ecology of mesophilic Aeromonas in the aquatic environment. In: Austin B, Altwegg M, Gosling PJ, Joseph SW, editors. The Genus: Aeromonas. 1. Chicester: Wiley; 1996.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical